Risk factors for cervical abnormalities among hong kong chinese women: A large-scale community-based cervical screening program

Journal of Women's Health

Volumn 20, Issue 1, 2011, Pages 53-59

  Wong, Heidi Y M ^a,c   Loke, Alice Y ^b   Chan, Norman H L ^a,d  

^a Prince of Wales Hospital   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c Union Hospital   (Hong Kong)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ABORTION; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CANCER SCREENING; CHINESE; CONDOM; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HONG KONG; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MARRIAGE; MASS SCREENING; ORAL CONTRACEPTION; PAPANICOLAOU TEST; PARITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SMOKING HABIT; SPONTANEOUS ABORTION; UTERINE CERVIX CANCER; UTERINE TUBE LIGATION; VAGINA BLEEDING;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CERVIX UTERI; COITUS; COMMUNITY HEALTH SERVICES; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HONG KONG; HUMANS; MARITAL STATUS; MASS SCREENING; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 79251531165     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1866     Document Type: Article

References (28)

1. World Health Organization. New vaccines against cervical cancer major opportunity for developing world, 2005. Available at www.who.int/mediacentre/ news/releases? 2006/pr73/en? Accessed April 10, 2009.
2. Hong Kong Cancer Registry. Hospital Authority, Hong Kong Government, Department of Health. Reports on statistics of cervical screening, 2004-2006. Available at www3.ha.org.hk/cancereg/e-rank.pdf, http://www3.ha.org.hk/cancereg/ e-cx.pdf Accessed April 1, 2009.
3. Cancer Research UK. Cervical screening in the UK: Sum-mary statistics from the Cervical Screening Programme in England, 2007-08. Available at info.cancerresearchuk.org? cancerstats/types/cervix/screening/?a=5441 Accessed April 5, 2009.
4. Pei GK, Cheng KK, Hedley AJ. The health and health care choices of women in Hong Kong. HK Practitioner 1991; 13:1714-1728.
5. Adab P, McGhee SM, Yanava J, Wong LC, Wong CM, Hedley AJ. The Pattern of cervical cancer screening in Hong Kong. Hong Kong Med J 2006;12:15-18.
6. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-S66.
7. Gram IT, Macaluso M, Stalsberg H. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap smear in an opportunistic screening. Acta Obstet Gynecol Scand 1998;77:228-232.
8. Gupta S, Sodhani P, Halder K, et al. Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: Implications for resource limited settings. Eur J Obstet Gynecol Reprod Biol2007;134:238-242.
9. Cheung ANY, Szeto EF, Ng KM, et al. Atypical squamous cells of undetermined significance on cervical smears. Cancer (Cancer Cytopathol) 2004;102:74-80.
10. Sideri M, Spinaci L, Schettino F, et al. Risk factors for high-grade cervical intraepithelial neoplasia in patients with mild cytological dyskaryosis: Human papillomavirus testing versus multivariate tree analysis of demographic data. Cancer Epidemiol Biomarkers Prev 1998;7:237-241.
11. Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med 2000;9:439-445.
12. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-964.
13. Green J, de Gonzalez AB, Sweetland S, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: The UK national case-control study of cervical cancer. Br J Cancer 2003;89:2078-2086.
14. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contra-ceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet 2002;359:1085-1092.
15. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. Br J Cancer 2001;84: 1219-1926.
16. Shields TS, Brinton LA, Burk RD, et al. A case-control study of risk factors for invasive cervical cancer among U.S. wo-men exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 2004;13:1574-1582.
17. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-2654.
18. Hinkula M, Pukkala E, Kyyronen P, et al. A population-based study on the risk of cervical cancer and cervical in-traepithelial neoplasia among grand multiparous women in Finland. Br J Cancer 2004;90:1025-1029.
19. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: The IARC multi-centric case-control study. Lancet 2002;359:1093-1101.
20. Bayo S, Bosch FX, de Sanjose S, et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002;31:202-209.
21. Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: A case-control study nested within the Manchester cohort. Br J Cancer 2000;88:1565-1572.
22. Szarewski A, Jarvis MJ, Sasieni P, et al. Effect of smoking cessation on cervical lesion size. Lancet 1996;347:941-943.
23. Prokopczyk B, Cox JE, Hoffmann D, Wanggoner SE. Iden-tification of tobacco-specific carcinogen in the cervical mu-cus of smokers and nonsmokers. J Natl Cancer Inst 1997; 89:868-873.
24. Munoz N, Bosch FX, de Sanjose S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:423-431.
25. Patil V, Wahab SN, Zodpey S, Vasudeo ND. Development and validation of risk scoring system for prediction of cancer cervix. Ind J Public Health 2006;50:38-42.
26. Zhao FH, Forman MR, Belinson J, et al. Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer 2006;118:442-448.
27. Franceschi S, Rajkumar T, Vaccarella S, et al. Human pap-illomavirus and risk factors for cervical cancer in Chennai, India: A case-control study. Int J Cancer 2003;107:127-133.
28. Kjellberg L, Hallmans G, Ahren AM, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human pap-illomavirus infection. Br J Cancer 2000;82:1332-1338.